Trastuzumab resistance accompanies vasculogenic mimicry in HER2-positive breast cancer cells

被引：0
|
作者：
Shimoda, Masafumi [1 ]
Hori, Ami [1 ]
Noguchi, Shinzaburo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Trastuzumab resistance accompanies vasculogenic mimicry in HER2-positive breast cancer cells
    Shimoda, Masafumi
    Noguchi, Shinzaburo
    [J]. CANCER SCIENCE, 2018, 109 : 311 - 311
  • [2] Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
    Hori, Ami
    Shimoda, Masafumi
    Naoi, Yasuto
    Kagara, Naofumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    [J]. BREAST CANCER RESEARCH, 2019, 21 (01)
  • [3] Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
    Ami Hori
    Masafumi Shimoda
    Yasuto Naoi
    Naofumi Kagara
    Tomonori Tanei
    Tomohiro Miyake
    Kenzo Shimazu
    Seung Jin Kim
    Shinzaburo Noguchi
    [J]. Breast Cancer Research, 21
  • [4] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [5] Duration of trastuzumab for HER2-positive breast cancer
    Montemurro, Filippo
    Aglietta, Massimo
    [J]. LANCET ONCOLOGY, 2013, 14 (08): : 678 - 679
  • [6] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    [J]. LANCET, 2005, 366 (9486): : 634 - 634
  • [7] Trastuzumab emtansine for HER2-positive breast cancer
    Venkatesan, Priya
    [J]. LANCET ONCOLOGY, 2016, 17 (12): : E528 - E528
  • [8] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [9] HER2-Positive Breast Cancer: Beyond Trastuzumab
    Murphy, Conleth G.
    Fornier, Monica
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (05): : 410 - 415
  • [10] Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
    Sonnenblick, Amir
    Salmon-Divon, Mali
    Salgado, Roberto
    Ponde, Noam
    Loibl, Sibylle
    Denkert, Carsten
    Joensuu, Heikki
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Azaria, Amos
    Loi, Sherene
    Michiels, Stefan
    Sotiriou, Christos
    [J]. CANCER RESEARCH, 2020, 80 (04)
12345